Financial services research from TD Cowen indicates that CME Group holds a significant edge in its federal lawsuit contesting the Commodity Futures Trading Commission’s (CFTC) recent decisions on cryptocurrency perpetual futures products. The dispute arose after CME Group filed its complaint on June 18, 2026, in the U.S. District Court for the District of Columbia.
The suit targets the CFTC’s May 29 approvals, which greenlit prediction market operator Kalshi to launch Bitcoin perpetual futures and established a pathway for other futures exchanges to offer comparable instruments.
The regulator also signaled it would not block Coinbase from providing U.S. customers access to its offshore perpetual futures linked to digital assets.
CME Group contends that perpetual futures—contracts designed to mirror underlying asset prices indefinitely without any expiration or mandatory settlement date—do not satisfy the legal definition of a futures contract under the Commodity Exchange Act.
That statute, the exchange argues, requires some form of delivery or cash settlement tied to a specific future timeframe.
Instead, CME Group maintains these instruments more closely resemble swaps as defined under the Dodd-Frank Wall Street Reform and Consumer Protection Act.
The firm points out that the CFTC itself had previously signaled this view by soliciting public input on the topic in April 2025.
Critics within CME Group highlight the agency’s swift one-day approval of Kalshi’s product without a formal rulemaking process or detailed justification for shifting its earlier stance.
In a client note, Jaret Seiberg, managing director at TD Cowen’s Washington Research Group, evaluated the case and determined that CME enjoys clear strengths on both procedural and core legal grounds.
Procedurally, Seiberg highlighted robust arguments under the Administrative Procedure Act, citing the CFTC’s abrupt reversal from its prior swap-oriented position and the lack of thorough analysis or public explanation.
On the substantive side, the central question remains whether contracts without any expiration date can validly be treated as futures.
Seiberg expects CME Group to promptly seek a preliminary injunction halting implementation of the CFTC approvals while litigation proceeds.
Observers anticipate an initial status conference and scheduling order soon, with the court’s early decisions on injunctive relief likely proving decisive.
The outcome matters for several reasons. True futures products benefit from daily margining cycles and more advantageous tax rules compared with swaps, which carry longer margin periods and additional dealer obligations.
A victory for CME Group could restrict how perpetual futures—already a massive segment of global crypto trading—are offered and regulated in the United States, potentially reshaping competition between legacy exchanges, crypto-native platforms, and emerging prediction markets.
The CFTC has pushed back forcefully, describing the action as meritless “lawfare” driven by competitive fears rather than genuine regulatory principles, while reaffirming its support for responsible innovation in U.S. crypto markets.
As proceedings advance in Washington, D.C., the case is expected to draw sustained attention from derivatives professionals, crypto participants, and policymakers seeking greater regulatory predictability in this evolving space.